Emerging therapeutic targets for the treatment of malignant rhabdoid tumors
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging therapeutic targets for the treatment of malignant rhabdoid tumors
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 22, Issue 4, Pages 365-379
Publisher
Informa UK Limited
Online
2018-03-13
DOI
10.1080/14728222.2018.1451839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous
- (2018) Emilia M. Pinto et al. ACTA NEUROPATHOLOGICA
- Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
- (2017) Wenpeng Li et al. HUMAN GENE THERAPY
- Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors
- (2017) Shanta M. Messerli et al. MOLECULAR CANCER RESEARCH
- DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats
- (2017) David Brocks et al. NATURE GENETICS
- Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor
- (2017) Young Eun Lee et al. NEURO-ONCOLOGY
- The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity
- (2017) Jeffrey A Rubens et al. NEURO-ONCOLOGY
- Targeting Polo-like kinase 1 in SMARCB1 deleted atypical teratoid rhabdoid tumor
- (2017) Irina Alimova et al. Oncotarget
- Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma
- (2017) Simone Treiger Sredni et al. Oncotarget
- Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
- (2017) Natalia Moreno et al. Oncotarget
- Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
- (2017) Giles W. Robinson et al. Oncotarget
- High-Throughput Drug Screening Identifies Pazopanib and Clofilium Tosylate as Promising Treatments for Malignant Rhabdoid Tumors
- (2017) Céline Chauvin et al. Cell Reports
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors
- (2017) Adam W. Studebaker et al. Molecular Therapy-Oncolytics
- Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
- (2017) Peter Y. Yu et al. PLoS One
- Genomic and Epigenomic Alterations in Cancer
- (2016) Balabhadrapatruni V.S.K. Chakravarthi et al. AMERICAN JOURNAL OF PATHOLOGY
- Assessment of the treatment approach and survival outcomes in a modern cohort of patients with atypical teratoid rhabdoid tumors using the National Cancer Database
- (2016) Benjamin W. Fischer-Valuck et al. CANCER
- Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
- (2016) Jonathon Torchia et al. CANCER CELL
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
- (2016) Pascal D. Johann et al. CANCER CELL
- Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways
- (2016) Hye-Jung E. Chun et al. CANCER CELL
- MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation
- (2016) Angelina Stojanova et al. CELL CYCLE
- Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors
- (2016) A. Muscat et al. CLINICAL CANCER RESEARCH
- Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
- (2016) KM Morrissey et al. CTS-Clinical and Translational Science
- Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
- (2016) Stefaan W. van Gool et al. CYTOTHERAPY
- Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study—EpSSG NRSTS 2005
- (2016) Bernadette Brennan et al. EUROPEAN JOURNAL OF CANCER
- Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study
- (2016) Barbara C. Worst et al. EUROPEAN JOURNAL OF CANCER
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
- (2016) Xiaofeng Wang et al. NATURE GENETICS
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies
- (2016) Michael C. Frühwald et al. NEURO-ONCOLOGY
- Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2
- (2016) Martijn A. J. Koppens et al. TRANSGENIC RESEARCH
- Epigenome-based personalized medicine in human cancer
- (2016) Wenji Yan et al. Epigenomics
- The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
- (2016) Zhi-Yan Han et al. Nature Communications
- Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors
- (2016) Jocelyn P. Wong et al. Cell Reports
- Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007
- (2016) Kerstin Bartelheim et al. Cancer Medicine
- Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials
- (2016) Benjamin Lu et al. Cancers
- Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
- (2016) Tadas Rimkus et al. Cancers
- DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
- (2015) Olga Grishina et al. BMC CANCER
- Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
- (2015) R. H. Wijdeven et al. CANCER RESEARCH
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Investigation of the location of atypical teratoid/rhabdoid tumor
- (2015) Yun-Sik Dho et al. CHILDS NERVOUS SYSTEM
- SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
- (2015) E. H. Bell et al. CLINICAL CANCER RESEARCH
- Talimogene Laherparepvec: First Global Approval
- (2015) Sarah L. Greig DRUGS
- Late Effects of Treatment of Pediatric Central Nervous System Tumors
- (2015) Erika Roddy et al. JOURNAL OF CHILD NEUROLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature
- (2015) D. Schrey et al. JOURNAL OF NEURO-ONCOLOGY
- Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis
- (2015) Taewan Kim et al. JNCI-Journal of the National Cancer Institute
- Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
- (2015) Jonatan Darr et al. Molecular Cancer
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- (2015) Cynthia Wetmore et al. NEURO-ONCOLOGY
- Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28
- (2015) Phuong N. Le et al. PHARMACOLOGY & THERAPEUTICS
- Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
- (2015) Melanie F. Weingart et al. Oncotarget
- Epigenetic treatment of solid tumours: a review of clinical trials
- (2015) Clara Nervi et al. Clinical Epigenetics
- Role of MYC-Regulated Long Noncoding RNAs in Cell Cycle Regulation and Tumorigenesis
- (2015) Taewan Kim et al. JNCI-Journal of the National Cancer Institute
- Chromatin Remodelers: From Function to Dysfunction
- (2015) Gernot Längst et al. Genes
- Tumor-intrinsic oncogene pathways mediating immune avoidance
- (2015) Stefani Spranger et al. OncoImmunology
- Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics
- (2015) C. Kadoch et al. Science Advances
- SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
- (2014) Martin Hasselblatt et al. ACTA NEUROPATHOLOGICA
- SWI/SNF chromatin remodeling complexes and cancer
- (2014) Jaclyn A. Biegel et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB)
- (2014) M Benesch et al. BONE MARROW TRANSPLANTATION
- Vulnerabilities of Mutant SWI/SNF Complexes in Cancer
- (2014) Katherine C. Helming et al. CANCER CELL
- Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumorsin vitroandin vivoby targeting overexpressed Gli1
- (2014) Kornelius Kerl et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer epigenetics drug discovery and development: the challenge of hitting the mark
- (2014) Robert M. Campbell et al. JOURNAL OF CLINICAL INVESTIGATION
- Feasibility of Intensive Multimodal Therapy in Infants Affected by Rhabdoid Tumors – Experience of the EU-RHAB registry
- (2014) A. Seeringer et al. KLINISCHE PADIATRIE
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- Wnt pathway in atypical teratoid rhabdoid tumors
- (2014) Madhavi Chakravadhanula et al. NEURO-ONCOLOGY
- Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors
- (2014) Seung Ah Choi et al. NEURO-ONCOLOGY
- The central role of EED in the orchestration of polycomb group complexes
- (2014) Qi Cao et al. Nature Communications
- Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor—feasibility and efficacy of multimodal therapy in a long-term survivor
- (2014) Angela Seeringer et al. Cancer Genetics
- Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
- (2014) Kimberly H. Kim et al. Cancer Genetics
- The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
- (2013) Kornelius Kerl et al. BMC CANCER
- Molecular Pathways: SWI/SNF (BAF) Complexes Are Frequently Mutated in Cancer--Mechanisms and Potential Therapeutic Insights
- (2013) X. Wang et al. CLINICAL CANCER RESEARCH
- Extracranial rhabdoid tumours: what we have learned so far and future directions
- (2013) Bernadette Brennan et al. LANCET ONCOLOGY
- Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib
- (2013) Anjali Singh et al. Molecular Oncology
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
- (2013) K. J. Cohen et al. NEURO-ONCOLOGY
- Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
- (2013) E L Mora-Blanco et al. ONCOGENE
- Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes
- (2013) Diane K. Birks et al. PEDIATRIC BLOOD & CANCER
- A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study
- (2013) Trent R. Hummel et al. PEDIATRIC BLOOD & CANCER
- Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience
- (2013) Wafik Zaky et al. PEDIATRIC BLOOD & CANCER
- Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS)
- (2013) Uwe Kordes et al. PEDIATRIC BLOOD & CANCER
- Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
- (2013) Simon Wöhrle et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Aurora A kinase (AURKA) in normal and pathological cell division
- (2012) Anna S. Nikonova et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Histone deacetylases expression in atypical teratoid rhabdoid tumors
- (2012) Simone Treiger Sredni et al. CHILDS NERVOUS SYSTEM
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Targeting Aurora Kinase A enhances radiation sensitivity of atypical teratoid rhabdoid tumor cells
- (2012) Sujatha Venkataraman et al. JOURNAL OF NEURO-ONCOLOGY
- Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
- (2012) Irina Alimova et al. NEURO-ONCOLOGY
- A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)
- (2012) Jodi A. Muscal et al. PEDIATRIC BLOOD & CANCER
- In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model
- (2012) Markus Thiemann et al. Radiation Oncology
- Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system
- (2011) Christelle Dufour et al. CANCER
- Aurora A Is a Repressed Effector Target of the Chromatin Remodeling Protein INI1/hSNF5 Required for Rhabdoid Tumor Cell Survival
- (2011) S. Lee et al. CANCER RESEARCH
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
- (2011) F. Bourdeaut et al. CLINICAL CANCER RESEARCH
- Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience
- (2011) L. Lafay-Cousin et al. EUROPEAN JOURNAL OF CANCER
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival
- (2011) Diane K. Birks et al. NEURO-ONCOLOGY
- Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/rhabdoid tumor cells
- (2011) J. A. Knipstein et al. NEURO-ONCOLOGY
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome
- (2010) Reinhard Schneppenheim et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Systematic analysis of the antiproliferative effects of novel and standard anticancer agents in rhabdoid tumor cell lines
- (2010) Henning Lünenbürger et al. ANTI-CANCER DRUGS
- Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
- (2010) Velasco Cimica et al. BMC CANCER
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Reexpression of hSNF5 in Malignant Rhabdoid Tumor Cell Lines Causes Cell Cycle Arrest through a p21CIP1/WAF1-Dependent Mechanism
- (2010) Y. Kuwahara et al. CANCER RESEARCH
- Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report
- (2010) J. M. Su et al. CLINICAL CANCER RESEARCH
- DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells
- (2010) Kim INTERNATIONAL JOURNAL OF ONCOLOGY
- Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
- (2010) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets
- (2010) Samantha Gadd et al. LABORATORY INVESTIGATION
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
- (2010) Zainab Jagani et al. NATURE MEDICINE
- Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy
- (2010) Klaus Strebhardt NATURE REVIEWS DRUG DISCOVERY
- Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study
- (2010) Rani E. George et al. PEDIATRIC BLOOD & CANCER
- Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors
- (2010) Katherine W. Eaton et al. PEDIATRIC BLOOD & CANCER
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- CTNNB1 Gene Mutations, Pituitary Transcription Factors, and MicroRNA Expression Involvement in the Pathogenesis of Adamantinomatous Craniopharyngiomas
- (2010) Marina Lanciotti Campanini et al. Hormones & Cancer
- GDC-0449—A potent inhibitor of the hedgehog pathway
- (2009) Kirk D. Robarge et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
- (2008) Susan N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started